MyeloPro was established in December 2015 in Vienna, Austria.

 

We are located at the Vienna General Hospital (AKH) Campus at the premises of CeMM (Research Center for Molecular Medicine of the Austrian Academy of Sciences).

 

Our research focus is on developing therapeutics to treat myeloproliferative neoplasms.

 

We are currently in the discovery/hit-to-lead transition stage of research.